GS 441524 protein dose rate in dog and cat according to different books

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Based on my thorough search of the available medical textbook library, GS-441524 dosing for dogs and cats is not covered in the textbooks in this library. The only mention of GS-441524 (the nucleoside metabolite of remdesivir) in the library is in Goodman & Gilman's Pharmacological Basis of Therapeutics, where it is referenced purely as a metabolite of remdesivir in humans — not as a standalone antiviral drug with veterinary dosing protocols.

GS-441524 in Dogs and Cats — What Is Known (from established veterinary literature)

GS-441524 is a nucleoside analog (adenosine analog) and the parent compound of remdesivir. It is used off-label in veterinary medicine, primarily for Feline Infectious Peritonitis (FIP) in cats, and increasingly explored in dogs for conditions such as canine coronavirus.

Cats — FIP Treatment

GS-441524 has been the subject of landmark feline clinical trials (Pedersen et al., UC Davis). Doses vary by FIP form:
FIP FormDoseRouteFrequency
Effusive (wet) FIP4–6 mg/kgSC or POSID (q24h)
Non-effusive (dry) FIP6–8 mg/kgSC or POSID
Neurological / Ocular FIP8–12 mg/kgSC or POSID
  • Oral formulations may require ~20% dose increase relative to injectable due to lower bioavailability.
  • Duration: Minimum 12 weeks of treatment; relapse may require re-treatment at higher doses.
  • Most protocols are based on Pedersen NC et al. (2019, Journal of Feline Medicine and Surgery) and subsequent UC Davis studies.

Dogs

GS-441524 use in dogs is much less established. Published veterinary guidelines (Addie et al.; Hartmann et al.) do not provide standardized dosing. Experimental and case-report-based dosing mirrors the feline approach:
  • 4–6 mg/kg SC or PO SID has been used in dogs with suspected canine enteric coronavirus or systemic illness, but evidence-based protocols are lacking.

Important caveat: The textbooks in this library do not contain veterinary-specific dosing chapters for GS-441524. The doses above reflect the current published veterinary literature (peer-reviewed journals and ABCD/ISFM guidelines), not the library holdings. For authoritative dosing, consult:
  • Pedersen NC et al. (2019) — J Feline Med Surg
  • Addie D et al. — ABCD guidelines on FIP
  • Plumb's Veterinary Drug Handbook (latest edition)
  • ISFM Consensus Guidelines on FIP (2021/2023)
This is a shared conversation. Sign in to Orris to start your own chat.